Abbott Medical Devices

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Abbott Medical Devices sits in the top decile of US sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count).

261 total trials 23 currently recruiting 186 completed later-stage tilt top decile by trial count

Abbott Medical Devices: 261 sponsored US clinical trials, 23 recruiting.

Abbott Medical Devices sponsors 261 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 186 completed. 17 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 15 trials.

Top-decile sponsor footprint

Abbott Medical Devices ranks in the top decile of sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

186 of 211 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

261 total, page 3 of 6

COMPLETED Phase 4

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

NCT02836652
TERMINATED

A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device

NCT02858245
COMPLETED NA

A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems

NCT02738840
COMPLETED

PRESSUREwire Study

NCT02935088
COMPLETED NA

AMPLATZER™ Amulet™ LAA Occluder Trial

NCT02879448
COMPLETED

TARGET Post-Approval Study

NCT02800863
COMPLETED NA

MOMENTUM 3 Continued Access Protocol

NCT02892955
COMPLETED

MultiPoint Pacing™ Post Market Study

NCT02832622
COMPLETED NA

SJM MRI Diagnostic Imaging Registry (IDE)

NCT02807948
COMPLETED NA

Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With FIRM Guided Procedures

NCT02799043
COMPLETED NA

A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study

NCT02787291
COMPLETED NA

Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

NCT02548455
TERMINATED

MediGuide Registry

NCT02470312
TERMINATED NA

SHIELD II Clinical Investigation

NCT02468778
COMPLETED NA

HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve

NCT02097420
COMPLETED NA

OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation

NCT02471586
COMPLETED

Coronary Flow Reserve Following Orbital Atherectomy

NCT02339545
COMPLETED NA

TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study

NCT02310100
TERMINATED

ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study

NCT02353351
COMPLETED

CardioMEMS HF System Post Approval Study

NCT02279888
COMPLETED NA

Expanded Clinical Study of the Tendyne Mitral Valve System

NCT02321514
TERMINATED NA

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

NCT02130765
COMPLETED NA

Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures

NCT02274857
COMPLETED NA

MOMENTUM 3 IDE Clinical Study Protocol

NCT02224755
COMPLETED NA

PREVENtion of HeartMate II Pump Thrombosis

NCT02158403
TERMINATED

Optisure Lead Post Approval Study

NCT02235545
COMPLETED NA

Absorb IV Randomized Controlled Trial

NCT02173379
COMPLETED NA

Coronary Orbital Atherectomy System Study

NCT02132611
COMPLETED NA

Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions

NCT02229864
COMPLETED NA

Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant

NCT01993862
COMPLETED NA

The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker

NCT02030418
COMPLETED NA

SUNBURST (Success Using Neuromodulation With BURST) Study

NCT02011893
TERMINATED NA

MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing

NCT02006069
COMPLETED NA

CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients

NCT01983293
TERMINATED NA

SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study

NCT01990287
TERMINATED NA

EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension

NCT01903187
COMPLETED

Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)

NCT01930214
COMPLETED NA

Remote Device Interrogation In The Emergency Department

NCT01871090
COMPLETED NA

A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain

NCT01923285
COMPLETED NA

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)

NCT01923740
COMPLETED

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study

NCT01894152
COMPLETED

Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes

NCT01855412
COMPLETED Phase 3

MultiPoint Pacing IDE Study

NCT01786993
COMPLETED NA

Complete Lesion Assessment With ffR and IVUS TechnologY

NCT01941030
COMPLETED

St.Jude Medical Cardiac Lead Assessment Study

NCT01507987
COMPLETED

Advance Cardiac Resynchronization Therapy (CRT) Registry

NCT01805154
COMPLETED NA

Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal

NCT01938391
TERMINATED NA

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

NCT01650298
COMPLETED

Observational Study of OCT in a Patients Undergoing FFR

NCT01663896
COMPLETED NA

ABSORB III Randomized Controlled Trial (RCT)

NCT01751906
← Previous Page 3 of 6 Next →

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 1
Phase 3 11
Phase 4 6

Therapeutic Areas

Heart Failure 15
Coronary Artery Disease 10
Mitral Regurgitation 8
Bradycardia 8
Cardiac Pacemaker 5
Mitral Valve Regurgitation 4
Arrythmia 4
Atrial Fibrillation 4
Cardiac Arrhythmia 3
Cardiac Rhythm Disorder 3

Where Abbott Medical Devices enrollment is open (later-stage tilt)

23 recruiting of 261 indexed (9% open); 186 completed (71%).

Phase mix: 17 late (III/IV) vs 5 early (I/II) (later-stage heavy).

Top condition: Heart Failure (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Abbott Medical Devices: open-pipeline peers nationwide

Peers matched on 261 registered trials and 9% open enrollment, not the therapeutic-area sidebar.

Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 0%5%10%15%20%25% Total trials Recruiting share Abbott Medical DevicesPennington Biomedical Research CenterNovartisUniversity of Texas at AustinBoston Medical CenterGrifols TherapeuticsButler HospitalAMAG PharmaceuticalsIowa State University
Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 261 trials (± recruiting share)

Sponsors near 9% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Abbott Medical Devices page

261 registered trials is a research-attention snapshot, not an endorsement of Abbott Medical Devices or any single study.

  • 23 of Abbott Medical Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Heart Failure is the condition Abbott Medical Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Abbott Medical Devices pipeline card: 261 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.